Market Cap 3.54M
Revenue (ttm) 0.00
Net Income (ttm) -13.90M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 4,062,400
Avg Vol 198,038
Day's Range N/A - N/A
Shares Out 7.44M
Stochastic %K 4%
Beta 0.29
Analysts Strong Buy
Price Target $2.00

Company Profile

Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumors; and ETS2 driven diseases, inclu...

Industry: Biotechnology
Sector: Healthcare
Phone: 786 977 3380
Address:
1111 Lincoln Road, Suite 500, Miami Beach, United States
Takeiteasy30
Takeiteasy30 Nov. 21 at 12:59 AM
$KTTA Minus 91% since i posted and explained you whats happening here. Closed this short today - its nearly jackpot. Thanks
1 · Reply
Takeiteasy30
Takeiteasy30 Nov. 21 at 12:00 AM
$KTTA Mate you keep it real - i like your work as its saves me ton of fatigue to scroll it SEC documents by myself. Probably not agree with your all calls that are bullish but always read carefully your posts because they are valuable with information that matters in penny stock area. Thanks! P.S KTTA is well known scam - check their ,,office". Its circus
0 · Reply
PrimeZoneNews
PrimeZoneNews Nov. 20 at 10:24 PM
$KTTA In the KTTA (Pasithea) S-1, the company has not signed the deal yet. How do we know? Because the S-1 is clearly labeled: “Preliminary prospectus — subject to completion.” Additionally, there is no signing date listed anywhere in the document. This means: 👉 The Minimum Price has not been determined yet. 👉 The offering price is not final. 👉 The company is using a placeholder price ($0.7179) solely for calculation purposes. Under Nasdaq Rule 5635(d), the Minimum Price is defined as the higher of: 1. The closing price on the day before the company signs the agreement 2. The average closing price over the five trading days before signing If the deal were signed today — as I assumed based on the price drop — and the last closing price was $0.4151, then the requirement would be calculated as follows: Add $0.125 → $0.4151 + $0.125 = $0.5401
0 · Reply
TxTrader283
TxTrader283 Nov. 20 at 10:23 PM
$KTTA shouldn't this pump some before deadline to regain compliance on Dec 22nd?
0 · Reply
Cmash1
Cmash1 Nov. 20 at 10:13 PM
$AUID $IKT $KTTA $NVVE $ZONE adding more ZONE
1 · Reply
DaBullRunner
DaBullRunner Nov. 20 at 10:02 PM
🚨MNDR🚨👇🚨👇🚨👇🚨👇🚨👇🚨👇 $NVVE adding $AUID $IKT $KTTA $ZONE watching
0 · Reply
Johnv63
Johnv63 Nov. 20 at 9:52 PM
$KTTA lol that went to shit fast
0 · Reply
JOHNNY_DANGER
JOHNNY_DANGER Nov. 20 at 9:48 PM
$KTTA With those results and the company dumping 17 million shares at any price .10 is not out of the question.
0 · Reply
RAIK7
RAIK7 Nov. 20 at 9:35 PM
$KTTA First time in (not that! :-D) at 0,3080... let's see what happens tomorrow.
0 · Reply
JimBull
JimBull Nov. 20 at 9:15 PM
$KTTA pump for selling the offering , under $0.15 buying!
1 · Reply
Latest News on KTTA
Why Is Pasithea Therapeutics Stock Surging On Thursday?

Sep 26, 2024, 8:56 AM EDT - 1 year ago

Why Is Pasithea Therapeutics Stock Surging On Thursday?


Takeiteasy30
Takeiteasy30 Nov. 21 at 12:59 AM
$KTTA Minus 91% since i posted and explained you whats happening here. Closed this short today - its nearly jackpot. Thanks
1 · Reply
Takeiteasy30
Takeiteasy30 Nov. 21 at 12:00 AM
$KTTA Mate you keep it real - i like your work as its saves me ton of fatigue to scroll it SEC documents by myself. Probably not agree with your all calls that are bullish but always read carefully your posts because they are valuable with information that matters in penny stock area. Thanks! P.S KTTA is well known scam - check their ,,office". Its circus
0 · Reply
PrimeZoneNews
PrimeZoneNews Nov. 20 at 10:24 PM
$KTTA In the KTTA (Pasithea) S-1, the company has not signed the deal yet. How do we know? Because the S-1 is clearly labeled: “Preliminary prospectus — subject to completion.” Additionally, there is no signing date listed anywhere in the document. This means: 👉 The Minimum Price has not been determined yet. 👉 The offering price is not final. 👉 The company is using a placeholder price ($0.7179) solely for calculation purposes. Under Nasdaq Rule 5635(d), the Minimum Price is defined as the higher of: 1. The closing price on the day before the company signs the agreement 2. The average closing price over the five trading days before signing If the deal were signed today — as I assumed based on the price drop — and the last closing price was $0.4151, then the requirement would be calculated as follows: Add $0.125 → $0.4151 + $0.125 = $0.5401
0 · Reply
TxTrader283
TxTrader283 Nov. 20 at 10:23 PM
$KTTA shouldn't this pump some before deadline to regain compliance on Dec 22nd?
0 · Reply
Cmash1
Cmash1 Nov. 20 at 10:13 PM
$AUID $IKT $KTTA $NVVE $ZONE adding more ZONE
1 · Reply
DaBullRunner
DaBullRunner Nov. 20 at 10:02 PM
🚨MNDR🚨👇🚨👇🚨👇🚨👇🚨👇🚨👇 $NVVE adding $AUID $IKT $KTTA $ZONE watching
0 · Reply
Johnv63
Johnv63 Nov. 20 at 9:52 PM
$KTTA lol that went to shit fast
0 · Reply
JOHNNY_DANGER
JOHNNY_DANGER Nov. 20 at 9:48 PM
$KTTA With those results and the company dumping 17 million shares at any price .10 is not out of the question.
0 · Reply
RAIK7
RAIK7 Nov. 20 at 9:35 PM
$KTTA First time in (not that! :-D) at 0,3080... let's see what happens tomorrow.
0 · Reply
JimBull
JimBull Nov. 20 at 9:15 PM
$KTTA pump for selling the offering , under $0.15 buying!
1 · Reply
JesterOfWallSt
JesterOfWallSt Nov. 20 at 9:15 PM
$KTTA 🚀🚀🚀 $BBAI $MSTX $AMZE
0 · Reply
JesterOfWallSt
JesterOfWallSt Nov. 20 at 9:13 PM
$KTTA 🟢 Pasithea Therapeutics Announces Phase 1 Data From Its Ongoing First-In-Human Trial Evaluating PAS-004; Partial Response Observed In A MEK-Rechallenge 3rd-line Melanoma Patient With Braf V600e Mutation Who Remains On Trial For More Than 11 Months; PAS-004 Has Been Well-Tolerated With All Treatment $SMTK $NVVE $SHPH
0 · Reply
Justjohnn
Justjohnn Nov. 20 at 9:08 PM
$KTTA we waking up tomorrow to .25c?
0 · Reply
AlertsAndNews
AlertsAndNews Nov. 20 at 9:02 PM
$KTTA headline here Pasithea Therapeutics Announces Positive Phase 1 Data Including Partial Response, Demonstrating Monotherapy Clinical Activity and Favorable Safety Profile for PAS-004 in Advanced Cancer Study
0 · Reply
John_McClane911
John_McClane911 Nov. 20 at 7:34 PM
$KTTA But there is a chance of a rocket before they make RS. 7.44 M SHARES OUT
0 · Reply
JOHNNY_DANGER
JOHNNY_DANGER Nov. 20 at 7:28 PM
$KTTA folks the reason why its down is bwcause they filed to sell 17 million shares...Their gonna drive the sp down and than rs again.
1 · Reply
John_McClane911
John_McClane911 Nov. 20 at 7:20 PM
$KTTA The fight is on! Did you also see stocks running 300% in one day and you were thinking: "When do i get the chance to catch such a rocket?"
0 · Reply
BillionerOfKing
BillionerOfKing Nov. 20 at 3:11 PM
$KTTA Current Stock Price: $0.44
0 · Reply
DaBullRunner
DaBullRunner Nov. 19 at 9:41 PM
$NVTS there it goes … told you about this one in the $3’s 🚨SDA🚨🤝 TESLA = $5+ 🎯✅ I’m even willing to put some of my COIN TSLA profits into SDA👇💰💰💰 $YCBD $KTTA $CRNC $PACS let’s get it
0 · Reply
John_McClane911
John_McClane911 Nov. 19 at 8:34 PM
$KTTA Hi Shorties. Are you ready for a little game?
1 · Reply
John_McClane911
John_McClane911 Nov. 19 at 8:24 PM
$KTTA We just need a BIG FISH!
0 · Reply
John_McClane911
John_McClane911 Nov. 19 at 8:09 PM
$KTTA Pasithea Therapeutics Announces Activation of Clinical Trial Site at University of Alabama at Birmingham for Ongoing Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
0 · Reply